Sangamo Therapeutics to Regain Full Rights to Hemophilia A …
Dec 31, 2024 · Custom Report. La Merie Publishing offers the service of preparing customized reports tailored to the needs and specifications of the customer. We conduct scientific & …
ESSENCE Phase 3 trial results demonstrating statistically significant ...
Nov 20, 2024 · The trial achieved both its primary endpoints, with semaglutide 2.4 mg demonstrating statistically significant and superior improvements in liver fibrosis with no …
STORM Therapeutics Presents New Clinical Data on its First-in …
Nov 11, 2024 · STC-15 is well tolerated and demonstrates promising signs of clinical activity observed in multiple tumor types. Gene expression data shows upregulation of innate …
Neurizon's NUZ-001 Reduces Aggregation of Key ALS Disease …
Nov 20, 2024 · Highlights: Positive preclinical results in human in vitro iPSC Motor Neuron models of Amyotrophic Lateral Sclerosis (ALS) Neurizon’s lead drug NUZ-001 and its major active …
Seismic Therapeutic Presents New Preclinical Data for S-4321, a …
Nov 18, 2024 · Novel dual-cell bidirectional antibody engages two independent inhibitory receptors on multiple cell types in a single molecule. S-4321 is a low affinity PD-1 agonist with …
Capricor Therapeutics Completes Submission of Biologics License ...
Jan 2, 2025 · Custom Report. La Merie Publishing offers the service of preparing customized reports tailored to the needs and specifications of the customer. We conduct scientific & …
Capstan Therapeutics Presents Preclinical Data on Lead In Vivo …
Nov 18, 2024 · Custom Report. La Merie Publishing offers the service of preparing customized reports tailored to the needs and specifications of the customer. We conduct scientific & …
DATROWAY® Approved in Japan as the First TROP-2 Directed …
Dec 27, 2024 · First global approval based on TROPION-Breast01 where DATROWAY significantly reduced the risk of disease progression or death by 37% versus chemotherapy
Wave Life Sciences Announces Submission of First Clinical Trial ...
Dec 23, 2024 · Custom Report. La Merie Publishing offers the service of preparing customized reports tailored to the needs and specifications of the customer. We conduct scientific & …
REGENXBIO Presents Positive Data from the Phase II Study of …
Oct 21, 2024 · Custom Report. La Merie Publishing offers the service of preparing customized reports tailored to the needs and specifications of the customer. We conduct scientific & …